We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Technologies Promise Immediate Diagnosis for GI Patients

By HospiMedica staff writers
Posted on 29 May 2008
Confocal laser endomicroscopy (CLE) effectively and immediately identifies suspicious patterns and precancerous cells and may eliminate the need in many cases for biopsy to diagnose gastrointestinal (GI) conditions. More...
This could lead to earlier diagnosis and treatment of conditions including reflux disease, colon cancer, and inflammatory bowel disease.

Using a tiny microscope at the tip of an endoscope to provide highly magnified images, CLE allows for expanded diagnostic possibilities during endoscopy, which can help detect suspicious activity immediately. A study showed that doctors are now able to identify the same amount of precancerous cells using images from confocal laser CLE, as would have been found using traditional biopsy. This finding could reduce the number of biopsies taken because doctors using CLE would know whether precancerous cells existed, and therefore would not have to needlessly biopsy tissue that may not be abnormal.

Investigators used CLE to examine patients with Barrett's esophagus (BE), a condition that can often lead to esophageal cancer, in an effort to detect tiny precancerous lesions before they grow. One challenge with BE is that it can require several tissue biopsies, which are expensive, invasive, and can cause bleeding. Using CLE, researchers were able to magnify the lining of the esophagus 1,000 times, which enabled investigators to take biopsies only of areas that looked suspicious, instead of performing many unnecessary random biopsies.

"Up until now, determining the condition of a patient required days or even weeks while patients waited for a diagnosis; further, it has been difficult to detect subtle precancerous lesions or even areas within a larger lesion, often leading to time-consuming and labor-intensive procedures as well as uncertainty about missing something important,” said Pankaj J. Pasricha, M.D., FASGE, professor of medicine, gastroenterology, and hepatology, Stanford University School of Medicine (Stanford, CA, USA).

The confocal endomicroscopy system (CFM) can immediately distinguish benign from precancerous polyps of the colon with very high accuracy. The procedure allows clinicians to both diagnose and treat the condition at the time of the procedure, and it prevents unnecessary biopsies and removal of tissue.

Investigators used a catheter probe-based CFM system, which can be passed through the accessory channel of almost any endoscope. The CFM probe provides images of cells and the tiny blood vessels around the cells, similar to what pathologists look at under a standard microscope. The investigators performed the procedure on 26 patients in two phases.

First, they removed the polyps and waited for pathological results. Then they looked at the images to determine which cells appear abnormal and normal. They found that using CFM, they could predict the sensitivity and specificity of the polyps with 89% accuracy. Furthermore, investigators looked at small polyps that appeared to be benign that would normally have been removed. Using CFM, they were able to accurately detect that they were benign 98% of the time.

"This technique will fundamentally change how the two fields interact,” said Anna M. Buchner, M.D., Ph.D., from the Mayo Clinic (Jacksonville, FL, USA). "This procedure allows us to become endopathologists, and the result is that we will be able to better manage patients with gastrointestinal disorders.”

These findings were presented at Digestive Disease Week 2008, which took place on May 17-22, 2008, in San Diego (CA, USA).


Related Links:
Stanford University School of Medicine
Mayo Clinic

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.